Age-Related Changes in Pain Peptides CGRP and Substance P in Spinal Nerve Cells | Research

The takeaway

Aging increases CGRP and substance P expression in lumbar dorsal root ganglia in mice, contributing to the pain sensitization and inflammation associated with spinal degeneration.

Age-dependent increase
CGRP and substance P expression rises with age in lumbar DRG neurons, paralleling disc degeneration

What the researchers found

Chronological aging increases CGRP and substance P in lumbar DRG neurons, with concurrent signs of sensitization and inflammation that parallel disc degeneration.

Why it matters

Back pain is extremely common in aging populations but its molecular mechanisms are poorly understood. This study connects neuropeptide changes in sensory neurons to age-related disc degeneration.

The numbers in context

Calca/ATF3/BDNF ↑ linearly from 12mo; TAC1 protein ↑ 24mo; Nfkb1/Rela ↑; TNF/IL-6/IL-1β/COX-2 unchanged

How the study worked

Age-series mouse study with molecular analysis of neuropeptide expression, inflammatory markers, and sensitization indicators in lumbar DRG neurons.

Who was studied

Mice aged 3-24 months (lumbar DRG and SCDH analysis)

What this study cannot tell us

Mouse study — aging patterns may differ in humans. Correlative data cannot establish causation between neuropeptide changes and pain.

How to read the evidence

Animal study with correlative molecular data. Provides mechanistic insight but needs human validation.

When this study was published

Published in 2020. Neuropeptide-targeted pain therapies continue to be developed.

The bigger picture

Understanding the neuropeptide basis of age-related pain could lead to targeted therapies like CGRP or substance P blockers for chronic back pain in the elderly.

Questions still open

Would CGRP or NK1R antagonists reduce age-related back pain?
Are similar neuropeptide changes found in human aging DRG?
Do the neuropeptide changes cause pain or just accompany degeneration?

Common questions

Why does back pain increase with age?

This study shows that as mice age, their spinal nerve cells produce more CGRP and substance P — peptides that transmit and amplify pain signals. This molecular change accompanies disc degeneration and may explain why chronic back pain becomes more common with aging.

Could migraine drugs help with back pain?

Potentially. CGRP-blocking drugs approved for migraines target the same peptide found to increase in aging spinal nerves. If age-related CGRP elevation drives back pain, these drugs might help, though this hypothesis needs clinical testing.

Read the original research

Age-related molecular changes in the lumbar dorsal root ganglia of mice: Signs of sensitization, and inflammatory response.

JOR spine, 3(4), e1124

View on PubMed ↗Publisher’s paper ↗

Citation

Vincent, Kathleen; Dona, Chethana Prabodhanie Gallage; Albert, Todd J; Dahia, Chitra Lekha. (2020). Age-related molecular changes in the lumbar dorsal root ganglia of mice: Signs of sensitization, and inflammatory response.. JOR spine, 3(4), e1124. https://doi.org/10.1002/jsp2.1124